References
- Br J Surg v.77 Surgical therapy of esophageal carcinoma Muller JM;Erasmi H;Stelzner M;Zieren U;Pichlmaier H
- Nature v.319 Human p53 localized to short arm of chromosome 17 Miller C;Mohandas T;Wolf D(et al)
- Oncogene v.9 Molecular controls of apoptosis;sifferentiation;growth arrest primary response genes, protooncogenes, and tumor suppressor genes, as positive and negative modulators Hoffman B;Liebermann DA
- J Surg Oncol v.72 No prognostic significance of p53 expression in esophageal squamous cell carcinoma Kanamoto A;Kato H;Tachimori
- Virchows Archiv A Pathol Anat v.42 Significance of expression s a prognostic factor in esophageal squamous cell carcinoma Shimaya K;Shiozaki N;Inoue M(et al)
- Science v.254 A gene encoding an antigen recognized by cytolytic T lumphocyteroc a human melanoma van der Bruggen p;Traversari C; Chomez P(et al)
- Immunogenetics v.39 Structure, chromsome localization, and expression of 12 genes of the MAGE family De Plaen E;Arden K;Traversari C(et al)
- Hum Immumol The HLA system in the Korean Population Kim SJ;Nisperos B;Mickelson E(et al)
- Cancer Res v.55 Identification and intracellular location of MAGE-3 gene product Kocher T;Schulz-Trater E;Gudat F(et al)
- Cacer v.74 protein expression and prognosis in squamous cell carcinnoma on the esophagus Sarbia M;Porchen R;Borchard F(et al)
- Cancer v.74 high prevalency of p53 protein expression in patients with esophagea cancer in Linxian;Chinal and its relationship to progression and prognosis Wang DY;Xian YY;Tanaka M(et al)
- Cancer Res v.52 p53 mutation and protein accumulation during multistage human esophageal carcinogenesis Bennett W;Hollstein M;Metcalf R(et al)
- Cancer v.79 p53 protein accumulation and p53 gene mutation in esophagea carcinomas Coggi G;Bosari S;Roncalli M(et al)
- Int J Cancer v.63 Human esophagea carcinomas frequently express the tumer-rejection antigen of MAGE genes Inoue H;Mory M;Li J(et al)
- Anticancer Res v.17(1A) Expression of MAGE genes in esophagea squamous-cell carcinoma Quillien V;Raoul JL;Heresbach D;Collet B;Youjas L;Brasseur F
- Ine J Cancer v.63 Expression of MAGE genes in promary and metastatic cutaneous melanoma Brasseur F;Rimoldi D;Lienard D(et al)
- Int J Cancer v.64 Expression of the MAGE gene family in human head and neck squamous cell carcinomas Eura M;Ogi K;Chikamutsu K(et al)
- Gastoenerol v.109 The expression of tumor-rejection antigen MAGE genes in human gastrila carcinoma Inoue H;Mori M;Honda M(et al)
- Ann Surg v.224 Expression of MAGE genes in human colorectal carcinoma Mori M;Inoue H;Mimori K(et al)
- Int J Cancer v.64 Expression of the MAGE gene family in primary and metastatic human breast cancer;implications for tumor antigen-specific immunotherapy Russo V;Travesari C;Verrecchia A(et al)
- Int J Cancer v.8 MAGE-1 and MAGE-3 or -6 expression in neuroblastoma-rdlated pegiatric solid tumors ishida H;Matsumura T;Salgaller ML(et al)
- Int J Concer v.58 A member of the melanoma antigen-encoding gene(MAGE) family expressed in human skin during wound healing Becker JC;Gillitzer R;Brocker EB
- Cancer Res v.55 Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis Takahashi K;Schichijo S;Noguchi M(et al)
- Immunol Rev v.145 Genecoding for tumor antigen recognized by cytolytic;lymphocytes Van Pel A;van de Bruggen P;Coulie PG(et al)
- APMIS v.106 Melanoma Associated antigenes recognized by cytotoxic T lymphocute Kirkin AF;Dzhandzhugazyan K;Zeuthen J
- Int J Cancer v.63 Tumor regression responses in melanoma patiedts treated with a peptide encoded by gene MAGE-3 Marchand M;Weynants P;Rankin E(et al)
- Concer Res v.57 Analysis of MAGE-3-specific cytolytic T lymphocutes in human leukocyte antigen-A2 melanoma patients Valmori D;Lienard K;Waanders G(et al)